The stock market today is buzzing with fresh IPO activity, and Fabtech Technologies IPO has officially entered the primary market. The Mumbai-based engineering solutions provider has launched its maiden public issue, opening for bids on September 29 and scheduled to close on October 1.
Market Performance — IPO Size and Price Band
Fabtech Technologies is looking to raise ₹230 crore through a 100% fresh issue. The company plans to issue 1.2 crore equity shares within a price band of ₹181-₹191 per share.
For retail participants, the minimum application size is 75 shares, translating to an entry amount of ₹14,325 at the upper band.
Key IPO Structure:
- Issue Size: ₹230 crore
- Issue Type: Entirely fresh equity issue
- Price Band: ₹181 – ₹191
- Lot Size: 75 shares
- Issue Opens: September 29
- Issue Closes: October 1
- Listing Date (Tentative): October 7
- Allotment Finalisation (Tentative): October 3
Main News — How the Company Plans to Use the IPO Funds
Fabtech Technologies has clearly spelt out the intended deployment of the IPO proceeds:
- Working capital requirements to support ongoing projects
- Inorganic growth initiatives via strategic acquisitions
- General corporate purposes to strengthen operations
No projections or forward-looking assumptions have been added beyond the official disclosures.
Company Details — What Fabtech Technologies Does
Fabtech Technologies operates as a turnkey solutions provider for the pharmaceuticals, biotech, and healthcare sectors. The company manages complete project execution — from designing and engineering to procurement, installation, and testing of selected pharmaceutical equipment.
Its global footprint is fairly visible. As of June 2024, Fabtech Technologies had:
- Completed 35 projects
- Delivered across multiple international markets, including Saudi Arabia, Egypt, Algeria, Bangladesh, Ethiopia, Sri Lanka, and the UAE
The company functions as a full-stack partner for clients looking to set up or expand pharmaceutical manufacturing infrastructure.
Summary
The Fabtech Technologies IPO brings another industrial engineering player to the stock market today, with a ₹230 crore public issue structured entirely as a fresh equity offering. With clear allocations towards working capital and expansion plans, the company enters the listed space backed by 35 completed international projects and a strong domain focus in pharma and biotech infrastructure solutions.
